Abstract CT085: iCare 1: A prospective clinical trial to predict treatment response based on mutanome-informed computational biology in patients with AML and MDS
Leylah Drusbosky(University of Florida), Christopher R. Cogle(University of Florida), Kimberly E. Hawkins(University of Florida), Caitlin Tucker(University of Florida), Amjad Husain(Brigham and Women's Hospital), Taher Abbasi, Chandan Kumar(Cellworks Research (India)), Shireen Vali, Kabya Basu(Cellworks Research (India)), Ansu Kumar(Cellworks Research (India)), Randy A. Brown(University of Florida), Neeraj Singh(Willis-Knighton Cancer Center), John Hiemenz(Moffitt Cancer Center), John R. Wingard(University of Florida Health), Jack W. Hsu(University of Florida Health), Maxim Norkin(Centre Hospitalier Universitaire Vaudois)
Cited by 2
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
|Clinical Infectious Diseases|2008|2.7k